Clinical Trial on Treatment of Intraventricular Hemorrhage "CLEAR IVH"


Phase 2 Results

Summary of Purpose

The specific objective of this trial is to determine the lowest dose and dose frequency possible with the best pharmacokinetic and safety profile and it's ability to remove a blood clot from the ventricular system.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 November 2017.

1 Feb 2004 26 Dec 2007 1 Aug 2008 1 Aug 2008 1 Nov 2017 12 Mar 2009
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment